Sunday - November 15, 2026
University of Dundee Spinout Amphista Therapeutics Reaches Major Milestone as First Patient is Dosed With Their Frontline Degrader Drug
October 29, 2026
DUNDEE, Scotland, Oct. 29 -- The University of Dundee issued the following news release:

* * *

Dundee spinout Amphista therapeutics reaches major milestone as first patient is dosed with their frontline degrader drug

Fundamental research conducted in a University of Dundee laboratory that provided the basis for a novel protein degradation approach has paved the way for an new therapeutic candidate being tested in patients with acute myeloid leukaemia (AML). . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products